DD301620A9 - Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit - Google Patents

Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit Download PDF

Info

Publication number: DD301620A9
Authority: DD; German Democratic Republic
Prior art keywords: amylase; gene; mutated; mutant; enzyme
Prior art date: 1989-06-29

Application number

DD90342352A

Other languages

German (de)

English (en)

Inventor

Wilhelmus J Quax

Yves Laroche

Adrianus W H Vollebregt

Patrik Stanssens

Marc Lauwereys

Original Assignee

Gist Brocades Nv

Plant Genetic Systems Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-29

Filing date

1990-06-29

Publication date

1993-04-29

1990-06-29 Application filed by Gist Brocades Nv, Plant Genetic Systems Nv filed Critical Gist Brocades Nv

1990-06-29 Priority to DD90342352A priority Critical patent/DD301620A9/de

1993-04-29 Publication of DD301620A9 publication Critical patent/DD301620A9/de

Links

108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 114
102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 99
230000001965 increasing effect Effects 0.000 title description 10
230000000813 microbial effect Effects 0.000 title description 2
230000002378 acidificating effect Effects 0.000 title 1
238000000034 method Methods 0.000 claims abstract description 53
229920002472 Starch Polymers 0.000 claims abstract description 37
239000008107 starch Substances 0.000 claims abstract description 37
235000019698 starch Nutrition 0.000 claims abstract description 37
239000002253 acid Substances 0.000 claims abstract description 19
239000004753 textile Substances 0.000 claims abstract description 7
238000009990 desizing Methods 0.000 claims abstract description 6
244000005700 microbiome Species 0.000 claims abstract description 5
229940024171 alpha-amylase Drugs 0.000 claims description 80
239000004382 Amylase Substances 0.000 claims description 40
108090000623 proteins and genes Proteins 0.000 claims description 40
102000004190 Enzymes Human genes 0.000 claims description 33
108090000790 Enzymes Proteins 0.000 claims description 33
229940088598 enzyme Drugs 0.000 claims description 33
241000193830 Bacillus <bacterium> Species 0.000 claims description 24
241000588724 Escherichia coli Species 0.000 claims description 18
239000012634 fragment Substances 0.000 claims description 18
150000001413 amino acids Chemical class 0.000 claims description 16
229940025131 amylases Drugs 0.000 claims description 13
238000004519 manufacturing process Methods 0.000 claims description 13
125000003275 alpha amino acid group Chemical group 0.000 claims description 11
230000008569 process Effects 0.000 claims description 11
108010065511 Amylases Proteins 0.000 claims description 10
241000194108 Bacillus licheniformis Species 0.000 claims description 10
239000013604 expression vector Substances 0.000 claims description 10
238000006731 degradation reaction Methods 0.000 claims description 9
239000000203 mixture Substances 0.000 claims description 8
102000013142 Amylases Human genes 0.000 claims description 7
235000019418 amylase Nutrition 0.000 claims description 7
230000015556 catabolic process Effects 0.000 claims description 7
108091028043 Nucleic acid sequence Proteins 0.000 claims description 5
108091008146 restriction endonucleases Proteins 0.000 claims description 5
230000009466 transformation Effects 0.000 claims description 5
239000013605 shuttle vector Substances 0.000 claims description 4
241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
241000193385 Geobacillus stearothermophilus Species 0.000 claims description 3
230000029087 digestion Effects 0.000 claims description 3
239000000463 material Substances 0.000 claims description 3
238000010348 incorporation Methods 0.000 claims description 2
238000002955 isolation Methods 0.000 claims description 2
238000011084 recovery Methods 0.000 claims description 2
238000004513 sizing Methods 0.000 claims description 2
230000003625 amylolytic effect Effects 0.000 claims 3
230000003413 degradative effect Effects 0.000 claims 1
230000001105 regulatory effect Effects 0.000 claims 1
238000000926 separation method Methods 0.000 claims 1
230000002255 enzymatic effect Effects 0.000 abstract description 21
239000000126 substance Substances 0.000 abstract description 9
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract description 5
108091027305 Heteroduplex Proteins 0.000 abstract description 5
241000304886 Bacilli Species 0.000 abstract description 3
238000002703 mutagenesis Methods 0.000 description 46
231100000350 mutagenesis Toxicity 0.000 description 46
238000012216 screening Methods 0.000 description 33
239000013598 vector Substances 0.000 description 29
108020004414 DNA Proteins 0.000 description 28
230000035772 mutation Effects 0.000 description 23
239000013612 plasmid Substances 0.000 description 21
235000001014 amino acid Nutrition 0.000 description 18
229940024606 amino acid Drugs 0.000 description 16
239000002773 nucleotide Substances 0.000 description 15
125000003729 nucleotide group Chemical group 0.000 description 15
230000000694 effects Effects 0.000 description 14
229920001817 Agar Polymers 0.000 description 12
239000008272 agar Substances 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 12
239000011575 calcium Substances 0.000 description 9
210000004027 cell Anatomy 0.000 description 9
229960005091 chloramphenicol Drugs 0.000 description 9
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 9
238000002474 experimental method Methods 0.000 description 9
230000002779 inactivation Effects 0.000 description 9
238000012360 testing method Methods 0.000 description 9
238000010276 construction Methods 0.000 description 8
239000000243 solution Substances 0.000 description 8
239000003513 alkali Substances 0.000 description 7
238000010367 cloning Methods 0.000 description 7
238000011534 incubation Methods 0.000 description 7
108091034117 Oligonucleotide Proteins 0.000 description 6
108010076504 Protein Sorting Signals Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000000523 sample Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
229910003798 SPO2 Inorganic materials 0.000 description 5
101100478210 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spo2 gene Proteins 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
239000002585 base Substances 0.000 description 5
239000000872 buffer Substances 0.000 description 5
102000004169 proteins and genes Human genes 0.000 description 5
230000010076 replication Effects 0.000 description 5
238000002741 site-directed mutagenesis Methods 0.000 description 5
239000000758 substrate Substances 0.000 description 5
244000063299 Bacillus subtilis Species 0.000 description 4
235000014469 Bacillus subtilis Nutrition 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
102100034343 Integrase Human genes 0.000 description 4
101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 4
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
239000013611 chromosomal DNA Substances 0.000 description 4
238000012258 culturing Methods 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
101150009573 phoA gene Proteins 0.000 description 4
235000018102 proteins Nutrition 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
239000002002 slurry Substances 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
108020004705 Codon Proteins 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
238000001712 DNA sequencing Methods 0.000 description 3
108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
239000007993 MOPS buffer Substances 0.000 description 3
102000008300 Mutant Proteins Human genes 0.000 description 3
108010021466 Mutant Proteins Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
108020004682 Single-Stranded DNA Proteins 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
238000007792 addition Methods 0.000 description 3
230000003115 biocidal effect Effects 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
229940079826 hydrogen sulfite Drugs 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
231100000219 mutagenic Toxicity 0.000 description 3
230000003505 mutagenic effect Effects 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
230000007017 scission Effects 0.000 description 3
230000028327 secretion Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000011550 stock solution Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
239000006188 syrup Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
206010000234 Abortion spontaneous Diseases 0.000 description 2
229920000945 Amylopectin Polymers 0.000 description 2
229920000856 Amylose Polymers 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
229920001353 Dextrin Polymers 0.000 description 2
239000004375 Dextrin Substances 0.000 description 2
241000702374 Enterobacteria phage fd Species 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
108020005038 Terminator Codon Proteins 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
238000012411 cloning technique Methods 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
235000019425 dextrin Nutrition 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
239000011630 iodine Substances 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
239000003550 marker Substances 0.000 description 2
208000015994 miscarriage Diseases 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
150000007523 nucleic acids Chemical group 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
239000000047 product Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000037432 silent mutation Effects 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
208000000995 spontaneous abortion Diseases 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000003860 storage Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
YXGBAQKCCMQLGH-VQSBMGSQSA-N (2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2r,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-6-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dih Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](OC2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](OC=5C=CC(=CC=5)[N+]([O-])=O)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O YXGBAQKCCMQLGH-VQSBMGSQSA-N 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
101710165033 Alpha-amylase 2 Proteins 0.000 description 1
101710081721 Alpha-amylase A Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
241000193749 Bacillus coagulans Species 0.000 description 1
108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 1
108020004256 Beta-lactamase Proteins 0.000 description 1
125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
102100022624 Glucoamylase Human genes 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
NBGXQZRRLOGAJF-UHFFFAOYSA-N Maltulose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)(CO)OCC1O NBGXQZRRLOGAJF-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
241001045988 Neogene Species 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
239000004115 Sodium Silicate Substances 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
230000002411 adverse Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
150000004996 alkyl benzenes Chemical class 0.000 description 1
238000005267 amalgamation Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
239000007621 bhi medium Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
238000004040 coloring Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
230000006240 deamidation Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
229910001882 dioxygen Inorganic materials 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000004744 fabric Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000011049 filling Methods 0.000 description 1
230000000855 fungicidal effect Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
JCQLYHFGKNRPGE-HFZVAGMNSA-N maltulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-HFZVAGMNSA-N 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000033607 mismatch repair Effects 0.000 description 1
239000003471 mutagenic agent Substances 0.000 description 1
230000036438 mutation frequency Effects 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
GHLZUHZBBNDWHW-UHFFFAOYSA-N nonanamide Chemical group CCCCCCCCC(N)=O GHLZUHZBBNDWHW-UHFFFAOYSA-N 0.000 description 1
238000013021 overheating Methods 0.000 description 1
230000002688 persistence Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
230000006432 protein unfolding Effects 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000012106 screening analysis Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
229910052911 sodium silicate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
239000004474 valine Substances 0.000 description 1
235000020681 well water Nutrition 0.000 description 1
239000002349 well water Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Plant Pathology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Chemical Or Physical Treatment Of Fibers (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Tires In General (AREA)
Cigarettes, Filters, And Manufacturing Of Filters (AREA)

DD90342352A 1989-06-29 1990-06-29 Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit DD301620A9 (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DD90342352A DD301620A9 (de)	1989-06-29	1990-06-29	Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP89201735		1989-06-29
DD90342352A DD301620A9 (de)	1989-06-29	1990-06-29	Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit

Publications (1)

Publication Number	Publication Date
DD301620A9 true DD301620A9 (de)	1993-04-29

Family

ID=8202426

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD90342352A DD301620A9 (de)	1989-06-29	1990-06-29	Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit

Country Status (17)

Country	Link
US (1)	US5364782A (ja)
EP (1)	EP0410498B1 (ja)
JP (2)	JP3086249B2 (ja)
KR (1)	KR0165550B1 (ja)
CN (1)	CN1050220A (ja)
AT (1)	ATE166922T1 (ja)
BG (1)	BG61081B1 (ja)
BR (1)	BR9006818A (ja)
CA (1)	CA2030554C (ja)
DD (1)	DD301620A9 (ja)
DE (1)	DE69032360T2 (ja)
DK (1)	DK0410498T3 (ja)
ES (1)	ES2117625T3 (ja)
FI (1)	FI103285B1 (ja)
IE (1)	IE902369A1 (ja)
PT (1)	PT94560B (ja)
WO (1)	WO1991000353A2 (ja)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1654692A (en) *	1991-05-06	1992-12-21	Valio Finnish Co-Operative Dairies Association	Acid alpha-amylase
JPH07503363A (ja) *	1991-11-14	1995-04-13	ノボザイムスアクティーゼルスカブ	バシラス・リヘニフォルミス中で遺伝子を発現させる方法
AU5659094A (en) *	1992-12-09	1994-07-04	Yoshiyuki Takasaki	Novel acid- and heat-resistant alpha-amylase, process for producing the same, and method of liquefying starch by using the same
DK154292D0 (da) *	1992-12-23	1992-12-23	Novo Nordisk As	Nyt enzym
PT867504E (pt) *	1993-02-11	2003-08-29	Genencor Int	Alfa-amilase estavel a oxidacao
DK0670367T3 (da) *	1993-05-19	2003-11-24	Kao Corp	Flydendegørende alkalisk alfa-amylase, fremgangsmåde til fremstilling af denne og detergentsammensætning indeholdende denne
CA2173329C (en) *	1993-10-08	2011-07-12	Henrik Bisgard-Frantzen	Amylase variants
DE69434635D1 (en) *	1993-10-08	2006-04-27	Novo Nordisk As	Amylasevarianten
US5830837A (en) *	1994-11-22	1998-11-03	Novo Nordisk A/S	Amylase variants
MY111537A (en) *	1994-02-02	2000-07-31	Novo Nordisk As	A combined desizing and bleaching process.
US5824531A (en) *	1994-03-29	1998-10-20	Novid Nordisk	Alkaline bacilus amylase
TW255887B (en) *	1994-05-25	1995-09-01	Lilly Co Eli	Synthesis of benzoquinolinones
DK0772684T3 (da) *	1994-06-17	2005-12-12	Genencor Int	Amylolytiske enzymer afledt fra B. Licheniformis alpha-amylasen med forbedrede karakteristika
WO1996017056A1 (en) *	1994-12-02	1996-06-06	Institut Pasteur	Hypermutagenesis
KR100511499B1 (ko) *	1995-02-03	2005-12-21	노보자임스 에이/에스	소정 특성을 가지는 알파-아밀라제 돌연변이체를 디자인하는 방법
CN101117629B (zh) *	1995-02-03	2014-06-11	诺维信公司	淀粉酶变体
US6093562A (en) *	1996-02-05	2000-07-25	Novo Nordisk A/S	Amylase variants
US6440716B1 (en)	1995-02-03	2002-08-27	Novozymes A/S	α-amylase mutants
US7115409B1 (en)	1995-02-03	2006-10-03	Novozymes A/S	α-amylase mutants
AR000862A1 (es)	1995-02-03	1997-08-06	Novozymes As	Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del
KR19980702782A (ko) *	1995-03-09	1998-08-05	혼 마가렛 에이.	녹말 액화 방법
US5736499A (en) *	1995-06-06	1998-04-07	Genencor International, Inc.	Mutant A-amylase
JP3025627B2 (ja)	1995-06-14	2000-03-27	花王株式会社	液化型アルカリα−アミラーゼ遺伝子
AR003020A1 (es) *	1995-07-24	1998-05-27	Procter & Gamble	Composicion detergente que comprende una amilasa de estabilidad oxidativa aumentada y un sistema surfactante especifico.
WO1997010342A1 (en) *	1995-09-13	1997-03-20	Genencor International, Inc.	Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom
ES2432519T3 (es) *	1996-04-30	2013-12-04	Novozymes A/S	Mutantes de alfa-amilasa
US6197070B1 (en)	1996-05-15	2001-03-06	The Procter & Gamble Company	Detergent compositions comprising alpha combination of α-amylases for malodor stripping
US5958739A (en) *	1996-06-06	1999-09-28	Genencor International Inc.	Mutant α-amylase
US6066779A (en) *	1997-04-28	2000-05-23	Yan's Heterosis & Herbicide, Inc.	Crop heterosis and herbicide
US6080568A (en) *	1997-08-19	2000-06-27	Genencor International, Inc.	Mutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis
US6361989B1 (en)	1997-10-13	2002-03-26	Novozymes A/S	α-amylase and α-amylase variants
US6187576B1 (en)	1997-10-13	2001-02-13	Novo Nordisk A/S	α-amylase mutants
US6204232B1 (en)	1997-10-30	2001-03-20	Novo Nordisk A/S	α-amlase mutants
BRPI9911086B1 (pt)	1998-06-10	2016-08-02	Novozymes As	composição de limpeza, processo para tratar tecidos a máquina, e uso de uma mananase
US6410295B1 (en)	1999-03-30	2002-06-25	Novozymes A/S	Alpha-amylase variants
WO2000060059A2 (en)	1999-03-30	2000-10-12	NovozymesA/S	Alpha-amylase variants
EP1214441A1 (en) *	1999-09-01	2002-06-19	Novozymes A/S	Maltogenic amylase-modified starch derivatives
JP5571274B2 (ja)	2000-03-08	2014-08-13	ノボザイムスアクティーゼルスカブ	改変された特性を有する変異体
CN100491525C (zh)	2000-07-28	2009-05-27	汉高两合股份公司	从芽孢杆菌a7-7(dsm 12368)中提取的新型淀粉分解酶以及含有该新型淀粉分解酶的洗涤剂和清洗剂
US20020155574A1 (en) *	2000-08-01	2002-10-24	Novozymes A/S	Alpha-amylase mutants with altered properties
EP2308980A3 (en)	2000-08-01	2011-04-27	Novozymes A/S	Alpha-amylase mutants with altered properties
PL361363A1 (en)	2000-11-28	2004-10-04	Henkel Kommanditgesellschaft Auf Aktien	Novel cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
JP3753945B2 (ja)	2001-02-14	2006-03-08	ヒゲタ醤油株式会社	大腸菌とブレビバチルス属細菌間のプラスミドシャトルベクター
ATE449840T1 (de)	2001-05-15	2009-12-15	Novozymes As	Alpha-amylasevariante mit veränderten eigenschaften
DE10138753B4 (de) *	2001-08-07	2017-07-20	Henkel Ag & Co. Kgaa	Wasch- und Reinigungsmittel mit Hybrid-Alpha-Amylasen
DE10163748A1 (de)	2001-12-21	2003-07-17	Henkel Kgaa	Neue Glykosylhydrolasen
US20060042020A1 (en) *	2002-12-20	2006-03-02	Novozymes North America, Inc.	Treatment of fabrics, fibers, or yarns
EP2385104A1 (en) *	2003-04-01	2011-11-09	Danisco US Inc.	Variant Scytalidium thermophilium CBH1
ES2554635T3 (es)	2004-07-05	2015-12-22	Novozymes A/S	Variantes de alfa-amilasa con propiedades alteradas
DE102004047777B4 (de)	2004-10-01	2018-05-09	Basf Se	Alpha-Amylase-Varianten mit erhöhter Lösungsmittelstabilität, Verfahren zu deren Herstellung sowie deren Verwendung
CN100396777C (zh) *	2005-10-28	2008-06-25	南开大学	一种嗜热碱性α-淀粉酶及其编码基因
EP1876285A1 (de) *	2006-07-05	2008-01-09	DyStar Textilfarben GmbH & Co. Deutschland KG	Kombinierte Entmineralisierung und Entschlichtung von Textilfasermaterialien
KR20100088675A (ko)	2007-11-05	2010-08-10	다니스코 유에스 인크.	변경된 특성을 지닌 바실러스 종 ｔｓ-23 알파-아밀라아제의 변이체
US8206966B2 (en)	2007-11-05	2012-06-26	Danisco Us Inc.	Alpha-amylase variants with altered properties
AU2009212526A1 (en)	2008-02-04	2009-08-13	Danisco Us Inc.	TS23 alpha-amylase variants with altered properties
MX2010013113A (es)	2008-06-06	2010-12-21	Danisco Inc	Variantes de alfa-amilasa geobacillus stearothermophilus con propiedades mejoradas.
MX364987B (es) *	2008-06-06	2019-05-17	Danisco Us Inc	Alfa-amilasas variantes de bacillus subtilis y metodos de uso de las mismas.
WO2010036515A1 (en)	2008-09-25	2010-04-01	Danisco Us Inc.	Alpha-amylase blends and methods for using said blends
WO2011076897A1 (en)	2009-12-22	2011-06-30	Novozymes A/S	Use of amylase variants at low temperature
US20110150955A1 (en)	2009-12-23	2011-06-23	Shannon Elizabeth Klingman	Products and Methods for Reducing Malodor from the Pudendum
WO2011080353A1 (en)	2010-01-04	2011-07-07	Novozymes A/S	Stabilization of alpha-amylases towards calcium depletion and acidic ph
EP2357220A1 (en)	2010-02-10	2011-08-17	The Procter & Gamble Company	Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent
EP3404087A1 (en)	2010-02-10	2018-11-21	Novozymes A/S	Alpha-amylase variants with high stability in presence of a chelating agent
US9434932B2 (en)	2011-06-30	2016-09-06	Novozymes A/S	Alpha-amylase variants
EP3004342B1 (en)	2013-05-29	2023-01-11	Danisco US Inc.	Novel metalloproteases
WO2014194034A2 (en)	2013-05-29	2014-12-04	Danisco Us Inc.	Novel metalloproteases
US20160108388A1 (en)	2013-05-29	2016-04-21	Danisco Us Inc.	Novel metalloproteases
WO2014194032A1 (en)	2013-05-29	2014-12-04	Danisco Us Inc.	Novel metalloproteases
DK3080262T3 (da)	2013-12-13	2019-05-06	Danisco Us Inc	Serinproteaser af bacillus-arter
EP3910057A1 (en)	2013-12-13	2021-11-17	Danisco US Inc.	Serine proteases of the bacillus gibsonii-clade
KR20160099629A (ko)	2013-12-16	2016-08-22	이 아이 듀폰 디 네모아 앤드 캄파니	점도 조절제로서의 폴리 알파-1,3-글루칸 에테르의 사용
ES2835703T3 (es)	2013-12-18	2021-06-23	Nutrition & Biosciences Usa 4 Inc	Eteres de poli alfa-1,3-glucano catiónicos
WO2015123323A1 (en)	2014-02-14	2015-08-20	E. I. Du Pont De Nemours And Company	Poly-alpha-1,3-1,6-glucans for viscosity modification
EP3116914B8 (en)	2014-03-11	2021-04-21	E. I. du Pont de Nemours and Company	Oxidized poly alpha-1,3-glucan as detergent builder
US20170096653A1 (en)	2014-03-21	2017-04-06	Danisco Us Inc.	Serine proteases of bacillus species
US9714403B2 (en)	2014-06-19	2017-07-25	E I Du Pont De Nemours And Company	Compositions containing one or more poly alpha-1,3-glucan ether compounds
EP3158043B1 (en)	2014-06-19	2021-03-10	Nutrition & Biosciences USA 4, Inc.	Compositions containing one or more poly alpha-1,3-glucan ether compounds
DK3207129T3 (da)	2014-10-17	2020-02-24	Danisco Us Inc	Serinproteaser af bacillus-arten
DK3212781T3 (da)	2014-10-27	2019-12-16	Danisco Us Inc	Serinproteaser
DK3212662T3 (da)	2014-10-27	2020-07-20	Danisco Us Inc	Serinproteaser
CN107148472A (zh)	2014-10-27	2017-09-08	丹尼斯科美国公司	芽孢杆菌属物种的丝氨酸蛋白酶
EP3212783B1 (en)	2014-10-27	2024-06-26	Danisco US Inc.	Serine proteases
EP3957729A1 (en)	2014-10-27	2022-02-23	Danisco US Inc.	Serine proteases
CN108064306B (zh)	2014-12-23	2022-11-01	营养与生物科学美国4公司	酶促产生的纤维素
CN107835855B (zh)	2015-05-13	2022-05-13	丹尼斯科美国公司	AprL-进化枝蛋白酶变体及其用途
FI3307427T3 (fi)	2015-06-09	2023-11-09	Danisco Us Inc	Osmoottiset puhkeavat kapselit
WO2016201040A1 (en)	2015-06-09	2016-12-15	Danisco Us Inc.	Water-triggered enzyme suspension
WO2016201069A1 (en)	2015-06-09	2016-12-15	Danisco Us Inc	Low-density enzyme-containing particles
US11499146B2 (en)	2015-06-17	2022-11-15	Danisco Us Inc.	Bacillus gibsonii-clade serine proteases
JP7364330B2 (ja)	2015-11-05	2023-10-18	ダニスコ・ユーエス・インク	パエニバチルス（Ｐａｅｎｉｂａｃｉｌｌｕｓ）属種及びバチルス（Ｂａｃｉｌｌｕｓ）属種のマンナナーゼ
EP4141113A1 (en)	2015-11-05	2023-03-01	Danisco US Inc	Paenibacillus sp. mannanases
EP3374401B1 (en)	2015-11-13	2022-04-06	Nutrition & Biosciences USA 4, Inc.	Glucan fiber compositions for use in laundry care and fabric care
JP7045313B2 (ja)	2015-11-13	2022-03-31	ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー，インコーポレイテッド	洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物
WO2017083226A1 (en)	2015-11-13	2017-05-18	E. I. Du Pont De Nemours And Company	Glucan fiber compositions for use in laundry care and fabric care
US11920170B2 (en)	2015-12-09	2024-03-05	Danisco Us Inc.	Alpha-amylase combinatorial variants
EP3390625B1 (en)	2015-12-18	2023-09-06	Danisco US Inc.	Polypeptides with endoglucanase activity and uses thereof
CN105802940B (zh) *	2016-04-18	2019-04-16	广西大学	一种地衣芽胞杆菌高温α-淀粉酶突变体及其应用
JP2019518440A (ja)	2016-05-03	2019-07-04	ダニスコ・ユーエス・インク	プロテアーゼ変異体およびその使用
CN109072213A (zh)	2016-05-05	2018-12-21	丹尼斯科美国公司	蛋白酶变体及其用途
WO2017210295A1 (en)	2016-05-31	2017-12-07	Danisco Us Inc.	Protease variants and uses thereof
EP3472313B1 (en)	2016-06-17	2022-08-31	Danisco US Inc.	Protease variants and uses thereof
EP3535365A2 (en)	2016-11-07	2019-09-11	Danisco US Inc.	Laundry detergent composition
CN110312795B (zh)	2016-12-21	2024-07-23	丹尼斯科美国公司	蛋白酶变体及其用途
EP3559226B1 (en)	2016-12-21	2023-01-04	Danisco US Inc.	Bacillus gibsonii-clade serine proteases
US11453871B2 (en)	2017-03-15	2022-09-27	Danisco Us Inc.	Trypsin-like serine proteases and uses thereof
EP3601515A1 (en)	2017-03-31	2020-02-05	Danisco US Inc.	Delayed release enzyme formulations for bleach-containing detergents
MX2019014556A (es)	2017-06-30	2020-02-07	Danisco Us Inc	Particulas que contienen enzimas de baja aglomeracion.
US20200354708A1 (en)	2017-11-29	2020-11-12	Danisco Us Inc.	Subtilisin variants having improved stability
MX2020006518A (es)	2017-12-21	2020-10-28	Danisco Us Inc	Gránulos de fusión en caliente, que contienen enzimas, que comprenden un desecante termotolerante.
US20200359656A1 (en)	2018-02-08	2020-11-19	Danisco Us Inc.	Thermally-resistant wax matrix particles for enzyme encapsulation
EP3799601A1 (en)	2018-06-19	2021-04-07	Danisco US Inc.	Subtilisin variants
WO2019245704A1 (en)	2018-06-19	2019-12-26	Danisco Us Inc	Subtilisin variants
WO2020047215A1 (en)	2018-08-30	2020-03-05	Danisco Us Inc	Enzyme-containing granules
WO2020068486A1 (en)	2018-09-27	2020-04-02	Danisco Us Inc	Compositions for medical instrument cleaning
US12509672B2 (en)	2018-11-28	2025-12-30	Danisco Us Inc.	Subtilisin variants having improved stability
US20220220419A1 (en)	2019-05-24	2022-07-14	Danisco Us Inc	Subtilisin variants and methods of use
US20220306968A1 (en)	2019-06-06	2022-09-29	Danisco Us Inc	Methods and compositions for cleaning
US12157869B2 (en)	2019-07-10	2024-12-03	Jeffrey Dean Lindsay	Methods and compositions for reducing persistent odor in clothing and mitigating biofilms on various materials
US20230313209A1 (en) *	2020-08-18	2023-10-05	Novozymes A/S	Dispersins expressed with amylase signal peptides
EP4204553A1 (en)	2020-08-27	2023-07-05	Danisco US Inc.	Enzymes and enzyme compositions for cleaning
EP4284906A1 (en)	2021-01-29	2023-12-06	Danisco US Inc.	Compositions for cleaning and methods related thereto
EP4363565A1 (en)	2021-06-30	2024-05-08	Danisco US Inc.	Variant lipases and uses thereof
US20240384205A1 (en)	2021-09-03	2024-11-21	Danisco Us Inc.	Laundry compositions for cleaning
CN117957318A (zh)	2021-09-13	2024-04-30	丹尼斯科美国公司	含有生物活性物质的颗粒
CN118679251A (zh)	2021-12-16	2024-09-20	丹尼斯科美国公司	枯草杆菌蛋白酶变体和使用方法
WO2023114939A2 (en)	2021-12-16	2023-06-22	Danisco Us Inc.	Subtilisin variants and methods of use
EP4448750A2 (en)	2021-12-16	2024-10-23	Danisco US Inc.	Subtilisin variants and uses thereof
CN118974227A (zh)	2022-03-01	2024-11-15	丹尼斯科美国公司	用于清洁的酶和酶组合物
EP4525615A2 (en)	2022-05-14	2025-03-26	Novozymes A/S	Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
CN114875057A (zh) *	2022-06-14	2022-08-09	中农华威生物制药(湖北)有限公司	一种可高效表达饲用低温酸性α-淀粉酶的枯草芽孢杆菌的构建方法
WO2023250301A1 (en)	2022-06-21	2023-12-28	Danisco Us Inc.	Methods and compositions for cleaning comprising a polypeptide having thermolysin activity
CN120112635A (zh)	2022-09-02	2025-06-06	丹尼斯科美国公司	枯草杆菌蛋白酶变体及其相关方法
WO2024050339A1 (en)	2022-09-02	2024-03-07	Danisco Us Inc.	Mannanase variants and methods of use
EP4581119A1 (en)	2022-09-02	2025-07-09	Danisco US Inc.	Detergent compositions and methods related thereto
EP4615968A1 (en)	2022-11-09	2025-09-17	Danisco US Inc.	Subtilisin variants and methods of use
CN115806959B (zh) *	2022-12-23	2025-02-18	山东隆科特酶制剂有限公司	碱性淀粉酶突变体及其应用
WO2024163584A1 (en)	2023-02-01	2024-08-08	Danisco Us Inc.	Subtilisin variants and methods of use
CN120712348A (zh)	2023-03-06	2025-09-26	丹尼斯科美国公司	枯草杆菌蛋白酶变体和使用方法
EP4680013A1 (en)	2023-03-16	2026-01-21	Nutrition & Biosciences USA 4, Inc.	Brevibacillus fermentate extracts for cleaning and malodor control and use thereof
CN121909283A (zh)	2023-09-28	2026-04-21	丹尼斯科美国公司	具有改善的溶解度的变体角质酶及其用途
CN117305279B (zh) *	2023-10-08	2024-03-26	态创生物科技(广州)有限公司	高活性和高耐热性的α-淀粉酶突变体及其制备方法和应用
CN121969733A (zh)	2023-10-20	2026-05-01	丹尼斯科美国公司	枯草杆菌蛋白酶变体和使用方法
WO2026024921A1 (en)	2024-07-25	2026-01-29	The Procter & Gamble Company	Detergent composition comprising a subtilisin variant and methods of use
WO2026050315A1 (en)	2024-08-29	2026-03-05	Danisco Us Inc.	Subtilisin variants and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4394443A (en) *	1980-12-18	1983-07-19	Yale University	Method for cloning genes
CA1170202A (en) *	1981-01-15	1984-07-03	Susan Mickel	Process for cloning the gene coding for a thermostable alpha-amylase into escherichia coli and bacillus subtilis
DE3480411D1 (en) *	1983-07-06	1989-12-14	Gist Brocades Nv	Molecular cloning and expression in industrial microorganism species
US4740461A (en) *	1983-12-27	1988-04-26	Genetics Institute, Inc.	Vectors and methods for transformation of eucaryotic cells
US4717662A (en) *	1985-01-31	1988-01-05	Miles Laboratories, Inc.	Thermal stabilization of alpha-amylase
EP0208491B1 (en) *	1985-07-03	1993-08-25	Genencor International, Inc.	Hybrid polypeptides and process for their preparation
US5024943A (en) *	1985-11-07	1991-06-18	Gist-Brocades	Regulatory region cloning and analysis plasmid for bacillus
DK311186D0 (da) *	1986-06-30	1986-06-30	Novo Industri As	Enzymer
NO872932L (no) *	1986-07-18	1988-01-19	Gist Brocades Nv	Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
EP0285123A3 (en) *	1987-04-03	1989-02-01	Stabra AG	A method for complete mutagenesis of nucleic acids
WO1989001520A1 (en) *	1987-08-11	1989-02-23	Cetus Corporation	Procaryotic xylose isomerase muteins and method to increase protein stability

1990
- 1990-06-27 WO PCT/EP1990/001042 patent/WO1991000353A2/en not_active Ceased
- 1990-06-27 ES ES90201706T patent/ES2117625T3/es not_active Expired - Lifetime
- 1990-06-27 BR BR909006818A patent/BR9006818A/pt not_active Application Discontinuation
- 1990-06-27 US US07/623,953 patent/US5364782A/en not_active Expired - Lifetime
- 1990-06-27 CA CA002030554A patent/CA2030554C/en not_active Expired - Lifetime
- 1990-06-27 JP JP02509959A patent/JP3086249B2/ja not_active Expired - Lifetime
- 1990-06-27 AT AT90201706T patent/ATE166922T1/de not_active IP Right Cessation
- 1990-06-27 EP EP90201706A patent/EP0410498B1/en not_active Expired - Lifetime
- 1990-06-27 DE DE69032360T patent/DE69032360T2/de not_active Expired - Lifetime
- 1990-06-27 KR KR1019910700227A patent/KR0165550B1/ko not_active Expired - Fee Related
- 1990-06-27 DK DK90201706T patent/DK0410498T3/da active
- 1990-06-29 IE IE236990A patent/IE902369A1/en unknown
- 1990-06-29 CN CN90106811A patent/CN1050220A/zh active Pending
- 1990-06-29 PT PT94560A patent/PT94560B/pt not_active IP Right Cessation
- 1990-06-29 DD DD90342352A patent/DD301620A9/de unknown
1991
- 1991-02-11 BG BG93814A patent/BG61081B1/bg unknown
- 1991-02-25 FI FI910907A patent/FI103285B1/fi active
1999
- 1999-10-27 JP JP11305433A patent/JP2000197491A/ja active Pending

Also Published As

Publication number	Publication date
WO1991000353A3 (en)	1991-02-21
US5364782A (en)	1994-11-15
DE69032360T2 (de)	1998-12-03
WO1991000353A2 (en)	1991-01-10
AU638263B2 (en)	1993-06-24
PT94560B (pt)	1998-01-30
FI103285B (fi)	1999-05-31
AU5953890A (en)	1991-01-17
DK0410498T3 (da)	1999-03-22
IE902369A1 (en)	1991-06-19
JP3086249B2 (ja)	2000-09-11
DE69032360D1 (de)	1998-07-09
CA2030554A1 (en)	1990-12-30
PT94560A (pt)	1991-02-08
JP2000197491A (ja)	2000-07-18
CA2030554C (en)	2001-08-28
FI910907A0 (fi)	1991-02-25
BG93814A (bg)	1993-12-24
EP0410498B1 (en)	1998-06-03
KR0165550B1 (ko)	1999-01-15
IE902369L (en)	1990-12-29
KR920701449A (ko)	1992-08-11
BG61081B1 (bg)	1996-10-31
JPH04500756A (ja)	1992-02-13
EP0410498A3 (en)	1991-11-06
FI103285B1 (fi)	1999-05-31
CN1050220A (zh)	1991-03-27
EP0410498A2 (en)	1991-01-30
ATE166922T1 (de)	1998-06-15
ES2117625T3 (es)	1998-08-16
BR9006818A (pt)	1991-08-06

Legal Events

Date	Code	Title	Description
1992-05-07	NAA	Public notice for inspection of patent application
1993-04-29	A9	Laid open application accord. to par. 10.3 extension act

Publication	Publication Date	Title
DD301620A9 (de)	1993-04-29	Mutierte mikrobielle alpha-amylasen mit erhoehter waerme-, saeure- und/oder alkalibestaendigkeit
DE60310264T2 (de)	2007-07-05	Thermostabile alpha-amylase
EP1419255B1 (de)	2012-02-29	Eine neue gruppe von alpha-amylasen sowie ein verfahren zur identifizierung und gewinnung neuer alpha-amylasen
DE69432610T2 (de)	2004-04-01	Oxidationsstabile Alpha-Amylase
DE69636475T2 (de)	2007-05-03	Alkalische verflüssigende alpha-amylase codierendes gen
DE69825904T2 (de)	2005-09-01	Mutante alpha-amylase mit zusätzlicher disulfidverbindung
DE10163748A1 (de)	2003-07-17	Neue Glykosylhydrolasen
EP0459385B1 (de)	1996-01-17	Maltopentaose produzierende Amylasen
EP0740706B1 (de)	2005-10-19	Herstellung von akariogenen zuckerersatzstoffen
DE602004012072T2 (de)	2009-02-26	Varianten von enzymen der alpha-amylase-familie
DE69028010T2 (de)	1996-12-05	Mutiertes Enzym mit reduzierter Stabilität unter industriellen Anwendungsbedingungen
EP0751218B1 (de)	2004-09-01	Saccharose-Stoffwechsel-Mutanten
EP2646545B1 (de)	2016-09-07	TEMPERATURSTABILE ß-PYRANOSIDASE
DE3850456T2 (de)	1994-12-15	Klonierung des isoamylaseenzym kodierenden Gens und seine Verwendung zur Herstellung dieses Enzyms.
DE69435050T2 (de)	2009-01-08	Alpha-1,4-glucan lyase aus einem pilz, ihre reinigung, genklonierung und expression in mikroorganismen
DE69931615T2 (de)	2007-05-10	Varianten amylolytischer enzyme
WO2017133974A1 (de)	2017-08-10	Verbesserte waschleistung durch eine alpha-amylase aus bacillus cereus
AU638263C (en)	1995-09-28	Mutant microbial alpha-amylases with increased thermal, acid and/or alkaline stability
DE69937148T3 (de)	2012-05-03	Varianten der glukoamylase
DE4106525A1 (de)	1992-09-10	Verfahren zur verbesserung der stabilitaet von hochalkalischen proteasen
DE10059105A1 (de)	2002-06-06	Neue Cyclodextrin-Glucanotransferase (CGTase) aus Bacillus agaradherens (DSM 9948)
DE10036753A1 (de)	2002-02-21	Neues amylolytisches Enzym aus Bacillus sp. A 7-7 (DSM 12368)
WO2019228877A1 (de)	2019-12-05	Verbesserte waschleistung durch eine neue alpha-amylase aus fomitopsis pinicola (fpi)